E. Dennehy

发表

Development of a computerized assessment of clinician adherence to a treatment guideline for patients with bipolar disorder.

M. Crismon, T. Suppes, B. Witte, 2004, Journal of psychiatric research.

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation

M H Trivedi, A J Rush, A. Rush, 2004, Psychological Medicine.

Effectiveness of adjunctive antidepressant treatment for bipolar depression.

David J Miklowitz, Joseph R Calabrese, Laszlo Gyulai, 2007, The New England journal of medicine.

Alcohol and risky sex: in search of an elusive connection.

R. Bolton, J. Vincke, R. Mak, 1992, Medical anthropology.

Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.

A. Saykin, J. Cummings, P. Trzepacz, 2013, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Migraine history and response to lasmiditan across racial and ethnic groups

Simin K. Baygani, E. Dennehy, Larry Charleston, 2022, Current medical research and opinion.

Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD.

M. Thase, S. Wisniewski, L. Marangell, 2008, The Journal of clinical psychiatry.

Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis and non‐pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER‐1, UNCOVER‐2 and UNCOVER‐3)

D. Shrom, A. Menter, K. Reich, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Lasmiditan efficacy in migraine attacks with mild vs. moderate or severe pain

M. Peres, Simin K. Baygani, Raghavendra Vasudeva, 2021, Current medical research and opinion.

Implementation of the Texas Medication Algorithm Project patient and family education program.

Alexander L. Miller, M. Trivedi, M. Crismon, 2006, The Journal of clinical psychiatry.

Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania.

Alexander L. Miller, A. Rush, M. Trivedi, 2003, The Journal of clinical psychiatry.

Omega-3 fatty acids in bipolar disorder: clinical and research considerations.

A. Nierenberg, S. Wisniewski, G. Sachs, 2006, Prostaglandins, leukotrienes, and essential fatty acids.

Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine

P. Winner, L. Kerr, E. Dennehy, 2021, Clinical Pharmacokinetics.

Use of quetiapine in bipolar disorder: a case series with prospective evaluation.

T. Suppes, M. Frye, L. Altshuler, 2004, International clinical psychopharmacology.

Ixekizumab Is Effective in Subjects With Moderate to Severe Plaque Psoriasis With Significant Nail Involvement: Results From UNCOVER 3.

E. Dennehy, Lu Zhang, D. Amato, 2016, Journal of drugs in dermatology : JDD.

Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)

M. Lebwohl, F. Kerdel, K. Reich, 2017, The Journal of dermatological treatment.

Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years.

M. Thase, S. Wisniewski, E. Frank, 2006, Bipolar disorders.

Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.

J. Calabrese, A. Nierenberg, M. Thase, 2009, Bipolar disorders.

Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

M. Thase, S. Wisniewski, G. Sachs, 2007, The Journal of clinical psychiatry.

Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*D

S. Wisniewski, L. Marangell, E. Dennehy, 2014, Current medical research and opinion.

The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.

Joseph R Calabrese, J. Calabrese, M. Crismon, 2005, The Journal of clinical psychiatry.

The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings

R. Lipton, S. Silberstein, S. Dowsett, 2019, Headache.

Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings

S. Hendrix, S. Dowsett, E. Dennehy, 2023, Neurology. Clinical practice.

Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

M. Thase, S. Wisniewski, M. Otto, 2004, Bipolar disorders.

Evidence-based long-term treatment of bipolar II disorder.

T. Suppes, E. Dennehy, 2002, The Journal of clinical psychiatry.

The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD.

S. Wisniewski, L. Marangell, M. Bauer, 2009, Journal of affective disorders.

Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000.

J. Calabrese, M. Crismon, M. Toprac, 2002, The Journal of clinical psychiatry.

Guidelines for treatment of bipolar disorder

E. Dennehy, 2000, Current psychiatry reports.

Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

M. Thase, S. Wisniewski, D. Miklowitz, 2006, The Journal of clinical psychiatry.

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine

M. Case, S. Aurora, P. Goadsby, 2019, Brain : a journal of neurology.

Qualitative Research on Fatigue Associated with Depression: Content Validity of the Fatigue Associated with Depression Questionnaire (FAsD-V2)

L. Matza, D. Revicki, E. Dennehy, 2015, The Patient - Patient-Centered Outcomes Research.

Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials

H. Hochstetler, R. Shapiro, E. Dennehy, 2019, The journal of headache and pain.

Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder

M. Crismon, M. Toprac, T. Carmody, 2004, Psychiatry Research.

Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

M. Thase, S. Wisniewski, L. Marangell, 2011, Journal of affective disorders.

Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study

S. Aurora, R. Goodloe, E. Dennehy, 2020, Pain and Therapy.

Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis

R. Heine, Dara L. Schuster, D. Kendall, 2015, Diabetes Therapy.

The importance of unresolved fatigue in depression: costs and comorbidities.

J. Stephenson, D. Faries, E. Dennehy, 2015, Psychosomatics.

Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study

L. Marangell, J. Stephenson, D. Faries, 2015, Current medical research and opinion.

Increasing minority research participation through collaboration with community outpatient clinics: the STEP-BD Community Partners Experience

D. Miklowitz, J. Kogan, G. Sachs, 2009, Clinical trials.

Medication Algorithms for Bipolar Disorder

T. Suppes, E. Dennehy, 1999 .

Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls

G. Kay, E. Pearlman, E. Dennehy, 2020, Human psychopharmacology.

Correlates of functioning in bipolar disorder.

M. Thase, S. Wisniewski, M. Otto, 2008, Psychopharmacology bulletin.

First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo.

T. Suppes, T. Ketter, E. Dennehy, 2013, Journal of affective disorders.

Clinical and Functional Outcomes of Patients Who Experience Partial Response to Citalopram: Secondary Analysis of STAR*D

S. Wisniewski, L. Marangell, G. Balasubramani, 2014, Journal of psychiatric practice.

What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment

S. Ball, E. Dennehy, P. Classi, 2014, Annals of General Psychiatry.

Assessment of beliefs in the effectiveness of acupuncture for treatment of psychiatric symptoms.

T. Suppes, E. Dennehy, A. Webb, 2002, Journal of alternative and complementary medicine.

Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder.

R. Perlis, J. Kogan, G. Sachs, 2007, Psychopharmacology bulletin.

Derivation of a brief measure of agitation and aggression in Alzheimer's disease

E. Dennehy, K. Sarsour, D. Milton, 2013, International journal of geriatric psychiatry.

Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease

C. Lyketsos, J. Cummings, P. Trzepacz, 2012, International Psychogeriatrics.

Treatment and outcomes for patients with depression who are partial responders to SSRI treatment: post-hoc analysis findings from the FINDER European observational study.

K. Demyttenaere, P. López-Romero, S. Dowsett, 2014, Journal of affective disorders.

Brief Psychiatric Rating Scale Expanded Version: How do new items affect factor structure?

Alexander L. Miller, A. Rush, M. Trivedi, 2005, Psychiatry Research.

Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project

Alexander L. Miller, A. Rush, M. Trivedi, 2005, Psychological Medicine.

Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder.

M. Crismon, M. Toprac, T. Suppes, 2001, The Journal of clinical psychiatry.

Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report.

A. Nierenberg, M. Thase, J. Smoller, 2010, The Journal of clinical psychiatry.

The Prevalence and Diagnostic Validity of Short-Duration Hypomanic Episodes and Major Depressive Episodes

T. Suppes, E. Dennehy, Shefali Miller, 2016, Current Psychiatry Reports.

The safety, acceptability, and effectiveness of acupuncture as an adjunctive treatment for acute symptoms in bipolar disorder.

T. Suppes, I. Bernstein, E. Dennehy, 2009, The Journal of clinical psychiatry.

056 Impact of ixekizumab on palmoplantar plaque psoriasis compared to placebo and etanercept: results from UNCOVER 2

D. Shrom, A. Menter, K. Reich, 2016 .

A psychometric evaluation of the clinician‐rated Quick Inventory of Depressive Symptomatology (QIDS‐C16) in patients with bipolar disorder

A. Rush, M. Trivedi, M. Crismon, 2009, International journal of methods in psychiatric research.

The longitudinal course of bipolar disorder.

T. Suppes, E. Dennehy, T Suppes, 2000, The Journal of clinical psychiatry.